[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368308-105":59,"doc-detail-368308-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prostate-cancer-screening-in-the-middle-east-and-north-africa-a-cross-sectional-study-on-current-practices","Prostate cancer screening in the Middle East and North Africa - a cross-sectional study on current practices","","Prostate cancer represents a significant health burden in the Middle East and North Africa, where many diagnoses occur at advanced stages, mortality is high relative to incidence, and awareness remains limited. This study evaluates current prostate cancer screening practices across the region to support improved early detection and management. A cross-sectional survey was administered July 1, 2023 to November 8, 2024 to physicians from 19 countries using a validated questionnaire.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostate-cancer-screening-in-the-middle-east-and-north-africa-a-cross-sectional-study-on-current-practices/368308/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostate-cancer-screening-in-the-middle-east-and-north-africa-a-cross-sectional-study-on-current-practices/368308.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address about prostate cancer in the region?","Question",{"text":112,"@type":113},"It addresses late-stage diagnosis, high mortality relative to incidence, and low prostate cancer awareness in the Middle East and North Africa, where screening is not well established.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the survey conducted?",{"text":117,"@type":113},"A cross-sectional survey was conducted from July 1, 2023 to November 8, 2024 among physicians from 19 countries, using a validated questionnaire to assess screening practices, barriers, and education needs.",{"name":119,"@type":110,"acceptedAnswer":120},"What barriers and recommendations were identified to improve screening?",{"text":121,"@type":113},"The primary barrier was lack of patient awareness (51.2%), and 65.3% reported no formal training. Suggested improvements included better patient education (63.5%), increased training for health-care professionals (41.9%), and improved access to screening equipment (38.9%).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368308,1791253159,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","JNCI Cancer Spectrum, 2025, 9(2), pkaf019  \n[https://doi.org/10.1093/jncics/pkaf019](https://doi.org/10.1093/jncics/pkaf019)  \nAdvance Access Publication Date: February 8, 2025  \nArticle  \nProstate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices  \nOzlemAynaci , MD1, Yetkin Tuac , PhD2, Layth Mula-Hussain , MBChB, MSc, EF, FRCP EdinE3,4, Lubna Hammoudeh, MD5, Salameh Obeidat , MD5, Enas Abu Abeelh, MD6, Ahmed H. Ibrahim , MD7, Sepideh Mohammadipour, MD8, Bader Alali , MD9, Ahmed Jdaini , MD10, Ali Barki, MD10, Nesrine Mejri , MD11, Zeinab Alhaddad, MD12, Nadeem Pervez , MD13,  \nHussain Al Hussain , MD14, Mohamad Kadri, MD15, Mohamed A. Elfagieh, MD16, Adda Bounedjar, MD17, Moamin Junaid , MD18, Ahmed M. Badheeb , MD19, Ibrahim Abu Ghida, MD20,21, Shalini Moningi, MD22, Jonathan E. Leeman, MD22, Peter F. Orio, DO22, Paul L. Nguyen , MD22, Anthony V. D’Amico , MD, PhD22, Mutlay Sayan , MD22,􀀃  \n1Karadeniz Technical University, Trabzon 61080, T€urkiye  \n2Department of Statistics, Ankara University, Ankara 06100, T€urkiye 3Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada 4College of Medicine, Ninevah University, Mosul, Ninevah 41002, Iraq 5Oregon Health and Science University, Portland, OR 97239, United States 6Primary Health Care Corporation, Doha, Qatar  \n7Ain Shams University, Cairo 11566, Egypt 8Hacettepe University, Ankara 06100, T€urkiye 9Jaber Al Ahmad Hospital, Kuwait, Kuwait  \n10Mohammed VI University Medical Center, Oujda 60050, Morocco  \n11Abderrahmen Mami Hospital, Ariana 2080, Tunisia 12King Hamad University Hospital, Al Sayh, Bahrain 13Sheikh Shakhbout Medical City, Abu Dhabi 11001, UAE 14King Fahd Medical City, Riyadh 12231, Saudi Arabia  \n15AlBaironi Hospital, Damascus, Syria 16National Cancer Institute, Misurata, Libya 17University of Blida, Blida 09000, Algeria 18University of Ninevah, Mosul 41002, Iraq 19Hadhramout University, Mukalla, Yemen  \n20Burjeel Medical City, Abu Dhabi, United Arab Emirates 21Emirates Oncology Society, Dubai, United Arab Emirates  \n22Department of Radiation Oncology, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, United States 􀀃 Corresponding author: Mutlay Sayan, MD, Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, United States ([msayan@bwh.harvard.edu](msayan@bwh.harvard.edu)) .  \nAbstract  \nBackground: Prostate cancer is a substantial health concern in the Middle East and North Africa region, with many cases diagnosed at advanced stages, a high mortality to incidence ratio, and low prostate cancer awareness. This study aimed to evaluate prostate cancer screening practices in the region to inform effective early detection and management strategies.  \nMethods: A cross-sectional survey was conducted from July 1, 2023, to November 8, 2024, among physicians from 19 countries in the Middle East and North Africa region. The study used a validated questionnaire to assess prostate cancer screening practices, barriers, and educational needs.  \nResults: The survey had a response rate of 96.8% and 1163 participants. Of these participants, 34.7% routinely performed prostate cancer screenings, with 61.1% using prostate-specific antigen tests. The primary barrier was lack of patient awareness (51.2%) . In addition, 65.3% of participants had no formal training. To improve screening rates, participants suggested better patient education (63.5%), increased training for health-care professionals (41.9%), and improved access to screening equipment (38.9%) .  \nConclusion: This study revealed that prostate cancer screening rates were low, with barriers including a lack of patient awareness and formal training among physicians. Addressing these issues through culturally tailored education programs may improve early detection rates and ultimately reduce the burden of prostate can","cbCaia2KCMhAcs3F","https://ap.wps.com/l/cbCaia2KCMhAcs3F","pdf",621681,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What problem does the study address about prostate cancer in the region?\",\"answer\":\"It addresses late-stage diagnosis, high mortality relative to incidence, and low prostate cancer awareness in the Middle East and North Africa, where screening is not well established.\"},{\"question\":\"How was the survey conducted?\",\"answer\":\"A cross-sectional survey was conducted from July 1, 2023 to November 8, 2024 among physicians from 19 countries, using a validated questionnaire to assess screening practices, barriers, and education needs.\"},{\"question\":\"What barriers and recommendations were identified to improve screening?\",\"answer\":\"The primary barrier was lack of patient awareness (51.2%), and 65.3% reported no formal training. Suggested improvements included better patient education (63.5%), increased training for health-care professionals (41.9%), and improved access to screening equipment (38.9%).\"}]","Prostate cancer screening in the Middle East and North Africa - a cross-sectional study on current practices | PDF",1790176173,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33107563454c9a3d3282c55f9bf4fa28.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5d2e7294de263f79ed866e9b348f1d0.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c36989b73c8353365e8a36cbd1a8108a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a39ace4304fa15edfa20296f6edbe77.webp",980,1287]